当前位置: X-MOL首页最新SCI期刊查询及投稿分析系统 › MOLECULAR CARCINOGENESIS杂志
MOLECULAR CARCINOGENESIS
基本信息
期刊名称 MOLECULAR CARCINOGENESIS
MOL CARCINOGEN
期刊ISSN 0899-1987
期刊官方网站 http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1098-2744
是否OA
出版商 Wiley-Liss Inc.
出版周期 Monthly
始发年份 1988
年文章数 161
最新影响因子 4.6(2022)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学2区 BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学3区
ONCOLOGY 肿瘤学3区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 3.43 1.176 0.863
Biochemistry, Genetics and Molecular Biology
Cancer Research
75 / 191 60%
Biochemistry, Genetics and Molecular Biology
Molecular Biology
124 / 375 66%
补充信息
自引率 2.50%
H-index 81
SCI收录状况 Science Citation Index
Science Citation Index Expanded
官方审稿时间
网友分享审稿时间 数据统计中,敬请期待。
PubMed Central (PML) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0899-1987%5BISSN%5D
投稿指南
期刊投稿网址 http://mc.manuscriptcentral.com/mc-wiley
收稿范围

Molecular Carcinogenesis publishes articles describing discoveries in basic and clinical science of the mechanisms involved in chemical-, environmental-, physical (e.g., radiation, trauma)-, infection and inflammation-associated cancer development, basic mechanisms of cancer prevention and therapy, the function of oncogenes and tumors suppressors, and the role of biomarkers for cancer risk prediction, molecular diagnosis and prognosis. 


Areas of interest include but are not limited to:

  • Molecular and cellular mechanisms associated with normal homeostasis altered in neoplasia 
  • Molecular aspects of oncogenes, tumor suppressors, and their gene products in animal models and human cancer 
  • Epigenetic mechanisms related to cancer initiation, progression and therapy
  • Microenvironment and systemic regulations in cancer initiation and progression
  • Mechanisms of chemo- and dietary cancer prevention
  • Molecular cancer epidemiology
  • Biomarker discoveries for cancer risks, molecular pathology, prognosis and therapeutic response/resistance 
  • Mechanisms of developmental and approved cancer therapeutics and clinical trials (targeted-, immuno-, chemo-, radio-therapy) with clear molecular/cellular targets 
  • Biostatistics, bioinformatics and computational approaches for the aforementioned areas


Areas outside the scope of the journal include:

  • Studies with no relevance to cancer
  • Reporting genetic variants without functional validation 
  • Data mining from published data or publically available database without experimental validations 
  • Randomized clinical trials without a molecular target
  • Research in a cell-free system or a single cell line unless scientifically justified


收录体裁
投稿指南
投稿模板
参考文献格式
编辑信息

  Executive Board

Editor-in-Chief

 

Xiao-Jing Wang

University of Colorado Anschutz Medical Campus

 

 

 

Executive Editors

 

 

 

 

 

John DiGiovanni, PhD

 

Editor for Special Issues and Reviews

 

Professor, Pharmacy/Toxicology

 

University of Texas Austin

 

Profile Link

 

 

 

Jian Yu, PhD

 

Editor for translational cancer research

 

Professor, Pathology, Radiation Oncology

 

University of Pittsburg

 

Profile Link

 

 

 

Richard Eckert, PhD

 

Editor for Basic Cancer Research

 

Professor and Chair, Biochemistry & Molecular Biology

 

University of Maryland

 

Profile Link

 

 

 

Rajesh Agarwal, PhD

 

Editor for Cancer Prevention

 

Professor and Vice Chair

 

Pharmaceutical Sciences

 

University of Colorado Anschutz Medical Campus

 

 Profile Link

 

 

 

Xiao-Jing Wang, MD, PhD

 

Editor for Clinical Cancer Research

 

Professor, Pathology

 

University of Colorado Anschutz Medical Campus

 

Profile Link


Ming Tan, PhD

 

Editor for Molecular Epidemiology, Bioinformatics, Biostatistics

 

Professor and Chair

Biostatistics, Bioinformatics & Biomathematics

Georgetown University

 

Profile Link

 

 

 

Consulting Editors

 

Zigang Dong

Homel Institute Minnesota

 

Mien-Chie Hung

Chinese Medical University - Taiwan

 

Saraswati Sukumar

Johns Hopkins University

 

Stuart Yuspa

NCI


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug